Back to search

Article

Targeting Cooperation of Chronic Inflammation with Epigenetic Reprogramming Triggers a Synthetic Lethality in Glioblastoma Multiforme

2022-03-02

Abstract excerpt

<h4>Background: </h4> Without an effective strategy for targeted therapy, glioblastoma multiforme (GBM) is still incurable, with a median survival of only 15 months. Both chronic inflammation and epigenetic reprogramming are hallmarks of cancer. However, the mechanisms and consequences of their cooperation in GBM remain unknown. Methods Western blotting was carried out to detect levels of various histone modifica...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3a6b2515-6848-58b6-9c02-1980178308ab
DOI
10.21203/rs.3.rs-1394307/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting Cooperation of Chronic Inflammation with Epigenetic Reprogramming Triggers a Synthetic Lethality in Glioblastoma MultiformeDOI 10.21203/rs.3.rs-1394307/v1
Select a neighboring publication to make it the new centre.